[ad_1]
“I spoke with the director of the Cantacuzino Institute, Coronel Oancea, in the last period of time he focused a lot on what it means to increase the testing capacity. He is also working on an immunomodulatory drug, which will soon be on the market, and has taken steps to restart the old trivalent vaccine production line and begin testing, so that, as proposed at the institute, a starting next year to be able to produce the vaccine. The immunomodulatory drug will be launched at the end of the year, ”said Ciucă, according to Agerpres.
The specialists of the National Institute for Medical-Military Research-Development “Cantacuzino” have developed a new immunomodulating product, which has properties to stimulate immunity, causing a greater resistance of the organism to infections.
